Cargando…

Genetic determinants for chemo- and radiotherapy resistance in bladder cancer

Bladder cancer (BCa) is burdened by high rates of chemo- and radio-resistance. We reviewed and summarized the current evidence regarding the genetic determinants of resistance in patients treated with chemotherapy and/or radiotherapy (RT) for BCa. Genetic heterogeneity may preexist to treatment aris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mari, Andrea, D’Andrea, David, Abufaraj, Mohammad, Foerster, Beat, Kimura, Shoji, Shariat, Shahrokh F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760393/ https://www.ncbi.nlm.nih.gov/pubmed/29354495 http://dx.doi.org/10.21037/tau.2017.08.19

Ejemplares similares

A systematic review and meta‐analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens
por: Mari, Andrea, et al.
Publicado: (2018)

Management of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: a literature review with emphasis on the role of surgery
por: Abufaraj, Mohammad, et al.
Publicado: (2016)

The impact of moderate wine consumption on the risk of developing prostate cancer
por: Vartolomei, Mihai Dorin, et al.
Publicado: (2018)

Comparison of perioperative complications and health‐related quality of life between robot‐assisted and open radical cystectomy: A systematic review and meta‐analysis
por: Kimura, Shoji, et al.
Publicado: (2019)

Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization
por: D’Andrea, David, et al.
Publicado: (2019)

Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC)
por: Laukhtina, Ekaterina, et al.
Publicado: (2020)

Functional Outcomes after Local Salvage Therapies for Radiation-Recurrent Prostate Cancer Patients: A Systematic Review
por: Abufaraj, Mohammad, et al.
Publicado: (2021)

The rational and benefits of the second look transurethral resection of the bladder for T1 high grade bladder cancer
por: Soria, Francesco, et al.
Publicado: (2019)

Intravesical bacillus Calmette-Guérin for bladder cancer: are all the strains equal?
por: D’Andrea, David, et al.
Publicado: (2019)

Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature
por: Mari, Andrea, et al.
Publicado: (2017)

Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma
por: Pradere, Benjamin, et al.
Publicado: (2020)

Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer
por: Ilijazi, Dafina, et al.
Publicado: (2020)

Differential Prognosis and Response of Denovo vs. Secondary Muscle-Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis
por: Pones, Mario, et al.
Publicado: (2021)

Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis
por: Miura, Noriyoshi, et al.
Publicado: (2020)

Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis
por: Mori, Keiichiro, et al.
Publicado: (2022)

Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic Targets
por: Grossmann, Nico C, et al.
Publicado: (2021)

Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer
por: Katayama, Satoshi, et al.
Publicado: (2021)

Inflammatory bowel disease and prostate cancer risk: A systematic review
por: Haddad, Anoud, et al.
Publicado: (2020)

The significance of De Ritis ratio in patients with radiation-recurrent prostate cancer undergoing salvage radical prostatectomy
por: Quhal, Fahad, et al.
Publicado: (2020)

Diagnostic accuracy, clinical utility and influence on decision‐making of a methylation urine biomarker test in the surveillance of non‐muscle‐invasive bladder cancer
por: D'Andrea, David, et al.
Publicado: (2019)

Focal Neuroendocrine Differentiation of Conventional Prostate Adenocarcinoma as a Prognostic Factor after Radical Prostatectomy: A Systematic Review and Meta-Analysis
por: Kardoust Parizi, Mehdi, et al.
Publicado: (2019)

Performance of fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography imaging for lymph node staging in bladder and upper tract urothelial carcinoma: a systematic review
por: Aydh, Abdulmajeed, et al.
Publicado: (2020)

Comparative effectiveness of moderate hypofractionation with volumetric modulated arc therapy versus conventional 3D-radiotherapy after radical prostatectomy
por: Moll, Matthias, et al.
Publicado: (2022)

Update on systemic treatment of upper tract urothelial carcinoma: a narrative review of the literature
por: Gust, Kilian M., et al.
Publicado: (2021)

Association of erectile dysfunction and cardiovascular disease: an umbrella review of systematic reviews and meta‐analyses
por: Mostafaei, Hadi, et al.
Publicado: (2021)

Detection of Urothelial Bladder Cancer Based on Urine and Tissue Telomerase Activity Measured by Novel RT-TRAP-2PCR Method
por: Glukhov, Alexander, et al.
Publicado: (2021)

Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer
por: Schuettfort, Victor M., et al.
Publicado: (2021)

An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer
por: Soria, Francesco, et al.
Publicado: (2018)

Tetraploidy-Associated Genetic Heterogeneity Confers Chemo-Radiotherapy Resistance to Colorectal Cancer Cells
por: Galofré, Claudia, et al.
Publicado: (2020)

Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer
por: Quhal, Fahad, et al.
Publicado: (2021)

Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysis
por: Schuettfort, Victor M., et al.
Publicado: (2020)

Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
por: Mori, Keiichiro, et al.
Publicado: (2020)

Biomarkers for the prediction of oncologic outcomes in non-muscle invasive bladder cancer: state of affairs and new frontiers
por: Soria, Francesco, et al.
Publicado: (2018)

Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy
por: Mori, Keiichiro, et al.
Publicado: (2022)

Assessing the Performance of 18F-FDG PET/CT in Bladder Cancer: A Narrative Review of Current Evidence
por: Bacchiani, Mara, et al.
Publicado: (2023)

Ischemic Priapism in a 12 Year Old Patient Associated With Coronavirus Disease 2019 (COVID-19): A Case Report
por: Brönimann, Stephan, et al.
Publicado: (2022)

Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder
por: Laukhtina, Ekaterina, et al.
Publicado: (2021)

How to optimally manage elderly bladder cancer patients?
por: Soria, Francesco, et al.
Publicado: (2016)

Liquid biopsies in bladder cancer—did we find the Holy Grail for biomarker analyses?
por: Rink, Michael, et al.
Publicado: (2016)

Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis
por: Sari Motlagh, Reza, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ib28r25fu67pl61qhp58aqpdih